Arterial Switch Operation (ASO) for Transposition of Great Arteries (TGA)
Treatment for Congenital Heart Anomalies
Effectiveness
95%
Safety Score
45%
Clinical Trials
1
Participants
50K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
45
DangerousModerateSafe
Treatment Details
Time to Effect
Immediate (hemodynamic correction), critical early recovery, long-term monitoring
Treatment Duration
Single procedure (neonatal), lifetime specialized cardiac care
Evidence Quality
HIGHConfidence Score
98%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$200
Monitoring:$1,500
Side Effect Mgmt:$400
Total Annual:$2,100
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTICER
$40,000/QALY
QALYs Gained
25
Outcome-Based Costs
Cost per Responder
$2,210.53
Cost per Remission
$2,333.33
Arterial Switch Operation (ASO) for Transposition of Great Arteries (TGA) Outcomes
for Congenital Heart Anomalies
Efficacy Outcomes
Overall Effectiveness
+95%
Response Rate
+95%
Remission Rate
+90%
Common Side Effects
Coronary artery stenosis
+5%
Supravalvular pulmonary stenosis
+10%
Neoaortic root dilation/regurgitation
+15%
Arrhythmias
+5%
Mortality
+3%
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov